India Diabetes Care Market Competition, Forecast & Opportunities, 2027
News provided by
Share this article
Share this article
ResearchAndMarkets.com s offering.
The Indian Diabetes Care Market was valued at USD1530.3 million in value terms in FY2020 and is forecast to grow at CAGR of 7.94% in value terms to reach USD2408.39 million by FY2026.
The Indian Diabetes Care Market is witnessing consistent growth, owing to the increasing geriatric population, increasing diabetic population and the adoption of an unhealthy lifestyle leading to obesity that further increases the diabetic population. Moreover, factors such as advancing technology and increasing cost of living are continuously fueling the diabetes care market in India.
India Stem Cell (Acquisition; Production; Cryopreservation; Expansion & Subculture) Market Analysis, Competition Forecast & Opportunities, 2016-2020 & 2021-2026
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
India Stem Cell (Acquisition; Production; Cryopreservation; Expansion & Subculture) Market Analysis, Competition Forecast & Opportunities, 2016-2020 & 2021-2026
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
India $470 Million Stem Cell Market Competition Forecast & Opportunities, 2021-2026
February 16, 2021 04:18 ET | Source: Research and Markets Research and Markets Dublin, IRELAND
ResearchAndMarkets.com s offering.
The Indian Stem Cell Market was valued at USD 0.47 Billion in 2019 and is projected to grow at around 13% CAGR during FY 2021 - FY 2026.
Continuous advancements in tissue engineering is one of the prime factors boosting the Indian Stem Cell Market. Development of regenerative medicines coupled with growing cases of chronic and genetic diseases across the country are some of the other factors anticipated to drive the growth of stem cell market during the forecast years.
Moreover, availability of funds from the government and certain organizations is estimated to bode well for the growth of the Indian Stem Cell Market over the next five years.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The Indian Molecular Diagnostics Market stood at an estimated 920 million in FY 2020 and is projected to grow at a CAGR of around 10% until FY 2026, predominantly on account of rising cases of fatal and chronic diseases.
Moreover, spread of COVID-19 pandemic is expected to create more opportunities, which is anticipated to drive the market growth during the forecast period. Furthermore, government initiatives of raising funds for the country s molecular department is also expected to positively influence the market in the coming years.
However, since the department requires high competence and professional skillset, absence of the same can pose a hurdle. Also, with over 25% of the country s population being below poverty line and the rest of the population is either middle-class or lower middle-class, lack of funds and high cost of molecular diagnostics is also expected to hinder the growth of the market